Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
1 Day Agoview on linkedin
We are excited to announce that BioAgilytix has been recognized as one of Triangle Business Journal’s 2018 Leaders in Diversity winners! This marks the third time that we’ve been honored with this award, and are proud of the fact that BioAgilytix employees now represent over 25 countries from all over the world: https://lnkd.in/gVDaY6G
1 Day Agoview on linkedin
Join BioAgilytix’s Todd Lester on August 17th during the Annual Congress of International Drug Discovery Science and Technology for a presentation entitled “Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment”. Register here: https://lnkd.in/gzVXksj
4 Days Agoview on linkedin
Using new techniques that enable researchers to study gene expression, scientists have identified a rare cell type in airways that appears to play a key role in the biology of cystic fibrosis. This work could have broad implications for all diseases of the airway, including asthma, chronic obstructive pulmonary disease, and bronchitis. https://lnkd.in/gBw3jSf via Genetic Engineering & Biotechnology News
August 8, 2018Setting Yourself Up for Success: Advice for Early Career Scientists
August 1, 2018The Challenges Associated with Implementing New Bioanalytical Technologies
August 13, 2018BioAgilytix Recognized by Triangle Business Journal as a 2018 Leader in Diversity
July 17, 2018BioAgilytix Remains Committed to Diversity as Global Growth Accelerates
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
